1-15 of 50
Spotlight on Asia-Pacific: Practice Beyond Borders
MinuteCE®Spotlight on Asia-Pacific: Practice Beyond Borders
Hiraji Iwata, MD, PhD
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
Giuseppe Curigliano, MD, PhD
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
MinuteCE®Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
Komal Jhaveri, MD, FACP
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
MinuteCE®Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
Giuseppe Curigliano, MD, PhD
- advertisement
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
MinuteCE®Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
The Future of Oral SERDs: Combination Strategies
MinuteCE®The Future of Oral SERDs: Combination Strategies
Komal Jhaveri, MD, FACP
Cynthia Villarreal-Garza, MD, DSc
Routes Reconsidered: A Case-Based Debate in SERD Selection
MinuteCE®Routes Reconsidered: A Case-Based Debate in SERD Selection
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Hiraji Iwata, MD, PhD
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
CME/CEContrasting TROP2-Targeted ADCs in Breast Cancer Therapy
Kevin Kalinsky MD, MS
Komal Jhaveri, MD, FACP
- advertisement
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
CME/CERevolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Sandra Swain, MD
Virginia Kaklamani, MD
Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
Sandra Swain, MD
Virginia Kaklamani, MD
